Hyperparathyroidism and Asthenia. A New Deal?
Journal Title: International Journal of Clinical Endocrinology and Metabolism - Year 2017, Vol 3, Issue 1
Abstract
The profile of primary hyperparathyroidism (PHPT) changed profoundly over the course of the twentieth century. The highly symptomatic forms reported in the 1960s have progressively been replaced by forms with few symptoms and in some cases totally asymptomatic forms. As of 1991, with the increasing frequency of these new forms, several consensus meetings designed to define the criteria for establishing the operability of minimally-symptomatic hyperparathyroidism have been organized [1].
Authors and Affiliations
Sun Fui S Li, Bonnichon P
Keywords
Related Articles
- EP ID EP542530
- DOI 10.17352/ijcem.000028
- Views 62
- Downloads 0
A Rare Entity Pituitary FDG Uptake; What Should We Expect?
F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely accepted modality in order to evaluate the cancer patients for staging, restaging and treatment response evaluation. The i...
The Importance of Risk Stratification and Management of Newborn Babies of Women with a History of Graves’ disease
Thyroid hormones are important for early brain development. During pregnancy, both maternal and foetal thyroid hormones contribute to foetal brain development. Maternal Graves’ can lead to transplacental transfer of anti...
Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. The pathogenesis has not been fully deciphered. PCOS is associated with insulin resistance (IR), menstrual irregulariti...
Assessment of Prescription Pattern of Antidiabetic Drugs in the Outpatient Department of a Tertiary Care Hospital
Background: Glycemic control remains the major therapeutic objective for prevention of target organ damage and other complications arising from diabetes. Poor glycemic control in diabetes mellitus can be prevented by usi...
Active Phytoconstituents for Controlling Hypercholesterolemia: A Review
Hypercholesterolemia is patho-physiological condition of metabolism caused by incessant increase in blood cholesterol levels and might be a possible risk factor for many cardiovascular and its associated diseases. Due to...